Related by context. All words. (Click for frequent words.) 83 myocardial infarction 75 myocardial infarction stroke 75 nonfatal MI 74 reinfarction 73 ipsilateral stroke 73 repeat revascularization 72 myocardial infarctions 72 nonfatal myocardial infarction 72 nonfatal stroke 71 coronary revascularization 71 thrombotic events 71 acute myocardial infarction AMI 70 thromboembolic events 70 ischemic stroke 70 left ventricular dysfunction 70 unstable angina 69 cerebrovascular events 69 ischemic complications 69 systemic embolism 69 NSTEMI 69 cardiovascular mortality 69 recurrent VTE 69 cardiovascular hospitalization 69 LV dysfunction 69 acute coronary syndrome 69 recurrent myocardial infarction 68 resuscitated cardiac arrest 68 VT VF 68 cerebral infarction 68 cardiovascular disease CVD 68 Erythropoietic therapies may 68 cardiovascular hospitalizations 68 HF hospitalization 68 arterial thromboembolic events 68 unstable angina pectoris 68 acute myocardial infarction 67 infarctions 67 fatal myocardial infarction 67 carotid stenosis 67 periprocedural 67 recurrent ischemia 67 events MACE 67 cardioembolic stroke 67 ischemic cardiomyopathy 67 LVSD 67 MACCE 67 definite stent thrombosis 67 intracerebral hemorrhage 67 nonfatal myocardial infarction MI 67 ST elevation myocardial 66 target vessel revascularization 66 thromboembolism 66 thromboembolic 66 CVD mortality 66 binary restenosis 66 silent ischemia 66 proximal DVT 66 stroke transient ischemic 66 Myocardial infarction 66 nondiabetic patients 66 β blockers 66 revascularization procedures 66 revascularisation 66 symptomatic VTE 65 MIs 65 acute myocardial infarctions 65 non valvular atrial 65 myocardial ischemia 65 composite endpoint 65 postoperative AF 65 refractory ischemia 65 coronary artery disease 65 NYHA Class II 65 nonischemic 65 TEAEs 65 thrombotic complications 65 atherothrombotic disease 65 recurrent DVT 65 coronary heart 65 glycated hemoglobin levels 65 Events MACE 65 LVEF 64 infarction STEMI 64 systolic dysfunction 64 revascularization 64 ventricular tachycardia VT 64 stent thromboses 64 angina pectoris 64 biochemical recurrence 64 rebleeding 64 acute coronary syndromes 64 cardiac dysfunction 64 VTE 64 colorectal adenoma 64 ischemic strokes 64 ICD implantation 64 subclinical hypothyroidism 64 acute coronary 64 NATRECOR R 64 TAXUS Express Stent 64 XIENCE V PROMUS Stent 64 PSADT 64 macrovascular disease 64 stable angina 64 cardiovascular morbidity 64 postoperative complication 64 extrapyramidal symptoms 64 paclitaxel eluting stents 64 perioperative complications 64 intima media thickness 64 CHD CVD 64 ischemia driven 64 venous thrombosis 63 prostate cancer CaP 63 left ventricular systolic 63 ventricular arrhythmia 63 upper gastrointestinal bleeding 63 revascularizations 63 beta blocker therapy 63 nonfasting triglyceride levels 63 ventricular fibrillation VF 63 cardiogenic shock 63 torsades de pointes 63 noncardiac surgery 63 infarction 63 de ath 63 atrial fibrillation AF 63 undergoing CABG 63 valvular disease 63 ATACAND 63 postoperative mortality 63 undergoing coronary angiography 63 thrombolytic therapy 63 eplerenone 63 pulmonary embolism PE 63 atherothrombosis 63 multivessel disease 63 tachyarrhythmias 63 macrovascular events 63 venous thromboembolisms 63 normotensive 63 severe exacerbations 63 venous thromboembolic events 63 acute coronary syndromes ACS 63 atherothrombotic 63 sustained ventricular tachycardia 63 microalbuminuria 63 preserved ejection fraction 63 carotid atherosclerosis 63 CABG surgery 63 hemorrhagic complications 63 colorectal adenomas 63 venous thromboembolism 63 Stent thrombosis 63 noncardiac 62 recurrent stroke 62 ejection fractions 62 target lesion revascularization 62 subclinical atherosclerosis 62 thromboembolic complications 62 coronary disease 62 death reinfarction 62 ventricular tachyarrhythmia 62 myocardial infarctions MI 62 renal dysfunction 62 urgent coronary revascularization 62 asymptomatic PAD 62 undergoing coronary artery 62 renal insufficiency 62 venous thromboembolism VTE 62 thrombocytopenic 62 PLX STROKE targeting 62 ximelagatran 62 carotid artery blockage 62 infarct size 62 aneurysmal subarachnoid hemorrhage 62 coronary artery revascularization 62 Ischemic stroke 62 perioperative mortality 62 rhythm disturbances 62 recurrent venous thromboembolism 62 onset atrial fibrillation 62 paroxysmal AF 62 cerebral vasospasm 62 ARCOXIA 62 myocardial infarctions MIs 62 CABG 62 KIF6 carriers 62 patients undergoing CABG 62 systolic hypertension 62 intracranial stenosis 62 androgen deprivation 62 STEMI patients 61 rehospitalization 61 % CI #.#-#.# [006] 61 patients undergoing percutaneous 61 angiotensin converting enzyme inhibitor 61 endometrial carcinoma 61 hemorrhagic strokes 61 left ventricular hypertrophy 61 white matter hyperintensities 61 hip BMD 61 reperfusion therapy 61 microvascular complications 61 sudden cardiac death 61 vertebral fracture 61 microbleeds 61 cerebrovascular accident 61 unstable angina UA 61 lacunar 61 cardiovascular disease 61 haemorrhagic stroke 61 Myocardial Infarction 61 nonsignificant 61 macrovascular 61 angiographically 61 tirofiban 61 nonobstructive CAD 61 recurrent coronary 61 undergone radical prostatectomy 61 stroke myocardial infarction 61 postoperative atrial fibrillation 61 rosuvastatin #mg 61 Complication rates 61 ICD implants 61 carotid endarterectomy 61 underwent CABG 61 symptomatic intracranial 61 TAXUS Stent 61 postoperative complications 61 DES implantation 61 STEMI 61 inhospital 61 coronary intervention 61 unstable angina chest 61 prolonged QT interval 61 eptifibatide 61 atherothrombotic events 61 coronary blockages 61 artery reclogging 61 Hemorrhagic stroke 61 arterial calcification 61 noncardiovascular 61 lipid lowering agents 61 tenecteplase 61 Renal dysfunction 61 ischemic 61 endarterectomy 61 variceal bleeding 61 asymptomatic carotid stenosis 61 angina chest 61 VTEs 61 segment elevation myocardial 61 simvastatin ezetimibe 61 recurrent ischemic stroke 60 revascularization procedure 60 syncopal 60 XIENCE V demonstrated 60 elevated triglyceride levels 60 deep venous thromboses 60 radical prostatectomy RP 60 coronary interventions 60 carotid artery stenting CAS 60 TAVR 60 intracerebral hemorrhage ICH 60 infarction NSTEMI 60 nonfatal heart 60 angiotensin converting enzyme inhibitors 60 Venous thromboembolism 60 cerebrovascular accidents 60 hyperkalemia 60 Thrombolysis 60 thromboses 60 noncardiovascular mortality 60 pCR 60 clinically localized prostate 60 carotid intima media 60 intraventricular hemorrhage 60 Operative mortality 60 Myocardial Infarction MI 60 lowest tertile 60 Carotid Revascularization Endarterectomy vs. 60 deep vein thromboses 60 endometrial hyperplasia 60 thrombus aspiration 60 rFVIIa 60 Unstable Angina 60 microvascular disease 60 morphometric vertebral fractures 60 antiarrhythmic drug 60 reintervention 60 thrombotic 60 carotid plaques 60 cerebral microbleeds 60 aspirin clopidogrel 60 venous thrombotic events 60 recurrent ischemic 60 advanced adenomas 60 pericardial effusion 60 T2DM 60 lipid lowering drugs 60 thyrotropin levels 60 hyperacute 60 cerebrovascular disease 60 MetS 60 UA NSTEMI 60 lipid lowering therapy 60 ARIXTRA 60 P = .# 60 advanced adenoma 60 intensive statin therapy 60 NATRECOR ® 60 fibrinolysis 60 sirolimus stent 60 carotid IMT 60 Hypotension 60 VaD 60 cerebral infarctions 60 candesartan 60 femoral neck fracture 60 hypoxemia 60 Diabetic nephropathy 60 antithrombotic therapy 60 cryptogenic stroke 60 intravenous bisphosphonates 60 salmeterol HFA MDI 60 highest tertile 59 ezetimibe simvastatin 59 Ischemic 59 decompensated heart failure 59 tHcy 59 hypertension diabetes mellitus 59 spontaneous preterm delivery 59 tumor recurrence 59 periprocedural MI 59 ECG abnormalities 59 troponin T 59 stenting 59 peri procedural 59 asthma exacerbation 59 HbA 1c 59 intracerebral haemorrhage 59 nonfasting triglycerides 59 malignant neoplasm 59 carotid plaque 59 NMIBC 59 Peripheral arterial disease 59 acute myocardial infarction MI 59 CK MB 59 infarct 59 Intracerebral hemorrhage 59 CHD mortality 59 coronary revascularization procedures 59 Postoperative complications 59 statin therapy 59 percutaneous interventions 59 antihypertensive therapy 59 autonomic dysfunction 59 prospectively defined 59 angioplasty stenting 59 venous thromboembolic disease 59 cryptogenic 59 postoperative pulmonary 59 oral hypoglycemic agents 59 vertebral fractures 59 subclinical hyperthyroidism 59 nonvertebral fracture 59 ABCB1 59 Coronary artery disease 59 Major Adverse Cardiac 59 Acute coronary syndromes 59 thyrotoxicosis 59 torsade de pointes 59 Percutaneous Coronary Intervention 59 multivariate adjustment 59 ICDs implanted 59 Taxus Stent 59 carotid artery stenosis 59 PCa 59 Coronary Artery Bypass Graft 59 angiotensin receptor blockers ARBs 59 TIA transient ischemic 59 myocardial fibrosis 59 locoregional recurrence 59 NSTE ACS 59 atherosclerotic disease 59 TAXUS p value 59 angina myocardial infarction 59 hypoglycemic events 59 CYPHER Stent 59 Hemorrhagic strokes 59 myocardial infarct 59 atypical hyperplasia 59 serum calcium levels 59 asystole 59 rs# [002] 59 proliferative diabetic retinopathy 59 TAXUS stent 59 acute aortic dissection 59 chronic thromboembolic pulmonary 59 bypass grafting 59 hepatectomy 59 Acute myocardial infarction 59 echocardiographic 59 elevated CRP 59 hepatorenal syndrome 59 atrial fibrillation 59 atherogenic dyslipidemia 59 Nesiritide 59 ticlopidine 59 arrhythmias 59 anticoagulants blood thinners 59 stent thrombosis 59 HRQoL 59 contrast induced nephropathy 59 STEMIs 59 CC genotype 59 leiomyomas 59 obstructive CAD 59 VADT 59 post thrombotic syndrome 59 resynchronization therapy 59 ischemic cerebrovascular 59 intracerebral hemorrhages 59 liver transplant recipients 59 Acute Coronary Syndrome 59 ADHF 59 bronchial hyperresponsiveness 59 abdominal adiposity 59 IIIa inhibitor 59 warfarin therapy 59 CP CPPS 59 left ventricular LV 59 IPAH 59 embolic stroke 59 distant metastasis 59 reoperations 59 comorbid conditions 59 confidence interval #.#-#.# 59 Kaplan Meier analysis 59 Ischemic strokes 59 diastolic BP 59 severe hypoglycemia 59 sirolimus eluting stents 59 arterial revascularization 59 angiographic restenosis 59 infarcts 59 nontraumatic 58 perioperatively 58 postoperative morbidity 58 QRS duration 58 angina 58 subtrochanteric 58 myocardial infraction 58 valsartan 58 underwent coronary angiography 58 defibrillator CRT D 58 GP IIb IIIa inhibitors 58 incomplete revascularization 58 comorbidities 58 preintervention 58 pulmonary resection 58 intraoperative complications 58 bivalirudin 58 kidney transplant recipients 58 CYPHER ® Stent 58 coronary revascularisation 58 adenomatous polyps 58 hypoperfusion 58 severe hypoglycemic 58 antithrombotic therapies 58 pelvic lymphadenectomy 58 cilostazol 58 occlusive disease 58 atheroma volume 58 interstitial pneumonia 58 advanced neoplasia 58 primary percutaneous coronary 58 atrophic gastritis 58 serum creatinine levels 58 LV hypertrophy 58 ischemic lesions 58 atrioventricular valve 58 rosuvastatin 58 ischemic cardiovascular 58 irbesartan 58 endoleaks 58 hyperglycaemia 58 diabetes mellitus DM 58 variceal 58 Cypher Stent 58 hormone therapy estrogen 58 infective endocarditis 58 renal artery stenosis 58 tibolone 58 adenoma recurrence 58 anticoagulant warfarin 58 thromboembolic disease 58 angiographic outcomes 58 acute cholecystitis 58 NNT = 58 postintervention 58 intracranial hemorrhage ICH 58 hypercholesterolaemia 58 left ventricular ejection 58 acute ischemic stroke 58 colorectal neoplasia 58 Lp PLA2 58 enoxaparin 58 Uncontrolled hypertension 58 CTEPH 58 Ventricular Tachycardia 58 acute decompensation 58 HbA1c levels 58 diameter stenosis 58 prasugrel uh prevented 58 sinus node dysfunction 58 CHD 58 glomerular filtration 58 circulating EPCs 58 hippocampal atrophy 58 Torsades de Pointes 58 MGUS 58 coronary artery bypass 58 recurrent glioblastoma multiforme 58 persistent pulmonary hypertension 58 arterial occlusion 58 parathyroidectomy 58 Primary endpoints 58 PSA nadir 58 SLNB 58 MI myocardial infarction 58 malperfusion 58 thrombophilia 58 percutaneous intervention 58 gestational hypertension 58 pathologic fractures 58 ventricular arrhythmias 58 dalteparin 58 discontinuations due 58 noncarriers 58 Acute Coronary Syndromes ACS 58 Coronary artery bypass grafting 58 estimated glomerular filtration 58 RE LY ® 58 liver resection 58 dysglycemia 58 Prehypertension 58 Restenosis 58 dysfunction LVSD 58 clopidogrel 58 dyssynchrony 58 MADIT II 58 sotalol 58 glycated hemoglobin HbA1c 58 spontaneous preterm birth 58 symptomatic carotid stenosis 58 stent implantation 58 STEMI ST 58 Unstable angina 58 myocardial infarction ventricular fibrillation 58 valvular heart disease 58 serum triglycerides 58 lipid lowering medications 58 SCr 58 airflow obstruction 58 proliferative retinopathy 58 Radical prostatectomy 58 nodal metastases 58 olmesartan 58 QTc prolongation 58 neurologic complications 58 atrial arrhythmias 58 thrombolytic agents 58 hsCRP levels 58 COPD exacerbation 58 antiplatelet drugs 58 coronary artery calcium 58 cytoreductive surgery 58 XIENCE V vs. 58 thromboprophylaxis 58 TRITON TIMI 58 HMG CoA reductase inhibitors 58 recurrent atrial fibrillation 58 cTnT 58 psychiatric comorbidities 58 afib 58 bilateral oophorectomy 58 Pulmonary embolism 58 fondaparinux 58 gastrointestinal perforation 58 % CI #.#-#.# [002] 58 artery stenosis 58 preserved systolic 58 overt nephropathy 58 coronary stenosis 58 cerebral perfusion 58 radical nephrectomy 58 HIV HCV coinfected 58 MMSE scores 58 hepatic cirrhosis 58 Endothelial dysfunction 58 myocardial ischaemia 58 multivariate Cox 58 nondiabetic 58 angioplasties stents 58 colectomy 58 laboratory abnormalities 57 oxycodone CR 57 unfractionated heparin UFH 57 hemoglobin A1c levels 57 symptomatic pulmonary embolism 57 NYHA Class III 57 alteplase 57 EBRT 57 Acute Coronary Syndromes 57 T2 lesions 57 chlorambucil 57 carotid artery disease 57 hsCRP 57 lumiracoxib 57 Statin therapy 57 aged ≥ 57 salpingo oophorectomy 57 elevated LDH 57 antiplatelet therapy 57 pancreatectomy 57 tumor lysis syndrome 57 stenoses 57 prednisone prednisolone 57 computed tomography angiography 57 hemodynamic instability 57 platelet activation 57 urolithiasis 57 nonfatal pulmonary embolism 57 nadolol 57 oral anticoagulation therapy 57 Adjuvant chemotherapy 57 paroxysmal atrial fibrillation 57 retrospective cohort 57 renal flares 57 hyperhomocysteinemia 57 intracranial atherosclerosis 57 transurethral resection 57 haemorrhagic strokes 57 abciximab 57 carotid artery narrowing 57 ischemic heart 57 neurodevelopmental impairment 57 hypoglycemic episodes 57 untreated OSA 57 nodal metastasis 57 ruptured aneurysms 57 PAOD 57 gastric cardia 57 percutaneous coronary interventions 57 pulmonary exacerbation 57 atrioventricular block 57 subarachnoid hemorrhages 57 PRADAXA #mg 57 vascular disease 57 polyp recurrence 57 oral anticoagulant 57 nicardipine 57 anticoagulation therapy 57 CCyR 57 adjuvant radiotherapy 57 ventricular tachyarrhythmias 57 APOE e4 57 glycoprotein IIb IIIa inhibitors 57 #.#/#.# mmHg [001] 57 artery occlusion 57 Abdominal aortic aneurysms 57 androgen deficiency 57 fibrinolytic therapy 57 coronary artery bypass grafts 57 pericardial effusions 57 fluvastatin 57 VTE prophylaxis 57 nondiabetics 57 fatal arrhythmic 57 familial hypercholesterolemia 57 androgen suppression 57 platelet reactivity 57 liver histology 57 underwent angiography 57 severe neutropenia 57 adenoma 57 antiplatelet agents 57 bypass graft CABG surgery 57 colorectal cancer incidence 57 hyperparathyroidism 57 TT genotype 57 venous blood clots 57 concomitant medications 57 fibrinolytic 57 serum uric acid 57 intima media thickness IMT 57 octreotide LAR 57 Subarachnoid hemorrhage 57 neoadjuvant chemotherapy 57 rosuvastatin Crestor 57 SRBD 57 serum potassium 57 unfractionated heparin 57 coronary angiography 57 typical antipsychotics 57 CMV disease 57 atherosclerotic 57 thiazide diuretics 57 variant angina 57 macroalbuminuria 57 CYPHER ® 57 hepatocellular carcinoma HCC 57 transferrin saturation 57 secondary endpoint 57 ivabradine 57 aldosterone antagonist 57 systolic BP 57 cerebrovascular 57 PASI scores 57 bronchopulmonary dysplasia 57 apnea hypopnea index 57 serum phosphate 57 ACUITY trial 57 CABG coronary artery 57 reinterventions 57 induce orthostatic hypotension 57 ID TLR 57 pleural mesothelioma 57 cardiac resynchronization 57 chemoradiotherapy 57 acute ischemic 57 mL/min/#.# m 2 57 Afib 57 graft occlusion 57 prostate cancer PCa 57 ADPKD 57 Arrhythmias 57 urgent revascularization 57 ticagrelor 57 hypokalemia 57 preoperative chemotherapy 57 Acute Myocardial Infarction 57 reperfusion injury 57 aortic valve stenosis 57 adverse cytogenetics 57 thrombolysis 57 percutaneous coronary intervention 57 Coronary artery calcification 57 CABG surgeries 57 dose atorvastatin 57 colorectal carcinoma 57 Lp PLA 2 57 adrenalectomy 57 primary hypercholesterolemia 57 postmenopausal hormone therapy 57 prognostic variables 57 fragility fracture 57 % CI #.#-#.# [003] 57 ventricular dysfunction 57 antihypertensive medications 57 Sudden cardiac death 57 pacemaker implantation 57 elevated LDL cholesterol 57 nonfatal cardiovascular 57 cTnT levels 57 carotid endarterectomy CEA 57 pulmonary dysfunction 57 coronary arterial 57 HbA 1c levels 57 vascular inflammation 57 lobular breast cancer 57 NHANES III 57 cytogenetic abnormalities 57 coronary calcification 57 platelet inhibition 57 aminotransferase ALT 57 HSCT 57 Aortic stenosis 57 ICD shocks 57 venous thromboembolic 57 % CI #.#-#.# [007] 57 depressive symptomatology 57 radical retropubic prostatectomy 57 ejection fraction 57 hydroxyvitamin D levels 57 serum cholesterol 57 HNSCC 57 #mmHg [001] 57 confidence interval CI 57 recurrent miscarriage 57 nonvertebral fractures 57 progressive dyspnea 57 NYHA class 57 serous ovarian cancer 57 clot busting therapy 57 postoperative bleeding 57 ARVD 57 teriflunomide 57 arterial thrombosis 57 comorbidity 57 thromboembolic disorders 57 T1DM 57 loop diuretics 57 postprocedure 57 mm Stent 57 VIIBRYD 57 intact parathyroid hormone 56 diastolic hypertension 56 Atrial fibrillation AF 56 generalized edema 56 STRIDE PD 56 sinus rhythm 56 ketoacidosis hyperosmolar coma 56 obstructive coronary artery 56 OSAHS 56 SSc 56 intracerebral 56 albuminuria 56 cardiovascular 56 atypical ductal hyperplasia 56 poor metabolizers 56 FOLFOX4 56 serum PTH 56 coronary revascularizations 56 lymphadenectomy 56 Recurrent Stroke 56 angiotensin II receptor blockers 56 biochemical relapse 56 peripheral arterial occlusive disease 56 EXJADE 56 inflammatory rheumatic 56 cardiomyopathies 56 hypoglycaemic episodes 56 transient ischemic attack 56 Doxil ® 56 QTc intervals 56 eGFR 56 coinfected patients 56 retinal vein occlusion 56 transthoracic 56 ramipril 56 severe periodontitis 56 ST Segment Elevation 56 beta blockers ACE inhibitors 56 dyslipidaemia 56 DMARD 56 intra abdominal abscess 56 ventricular dysplasia 56 cerebral vascular disease 56 hepatotoxicity 56 Sudden Cardiac Death 56 HMG CoA reductase inhibitor 56 intracoronary 56 rate variability HRV 56 intravitreal injections 56 everolimus eluting stents 56 adrenal insufficiency 56 uncontrolled hypertension 56 salmeterol fluticasone propionate 56 syncope 56 neurologic outcomes 56 perfusion defects 56 perindopril 56 CrCl 56 circulatory diseases 56 Val HeFT 56 detrusor overactivity 56 necrotizing pancreatitis 56 pulmonary artery banding 56 mycophenolate mofetil 56 anti arrhythmic drug 56 Crohn Disease Activity 56 conjugated equine estrogen 56 neoadjuvant 56 percutaneous transluminal coronary angioplasty 56 Subgroup analyzes 56 Thal Dex 56 Combination therapy 56 certolizumab 56 antithrombotic 56 cirrhotic patients 56 recurrent wheezing 56 hypertensive 56 peptide BNP 56 diastolic blood pressures 56 GnRH agonists 56 intravesical therapy 56 p = NS 56 diastolic heart 56 adenotonsillectomy 56 FluCAM arm 56 tachyarrhythmia 56 target lesion revascularizations 56 aminotransferases 56 catheter angiography 56 CI #.#-#.# [001] 56 onset diabetes mellitus 56 thrombo embolic 56 recanalization 56 androgen suppression therapy 56 OPCAB 56 INTERHEART study 56 multivariable adjusted 56 chronic obstructive lung 56 restenosis reblockage 56 ventricular remodeling 56 neutrophil counts 56 hypogonadal men 56 neointimal hyperplasia 56 psychiatric morbidity 56 esophagogastric 56 Coronary artery bypass graft 56 elevated hsCRP 56 cardiac tamponade 56 nonmelanoma skin cancer 56 arteriography 56 ischemia 56 candesartan cilexetil 56 reblockage 56 symptomatic intracerebral hemorrhage 56 virological response 56 arterial stiffness 56 abnormal uterine bleeding 56 aneurysm rupture 56 p = #.# [002] 56 distensibility 56 ExTRACT TIMI 56 carotid artery stenting 56 Febrile neutropenia 56 Hypertrophic cardiomyopathy 56 repolarization 56 contrast echocardiography 56 recurrent acute pancreatitis 56 cerebral ischemia 56 coronary 56 Antihypertensive 56 gallstone disease 56 myopathy rhabdomyolysis 56 Thromboembolism 56 thiazide diuretic 56 atherosclerotic cardiovascular disease 56 cardiovascular ischemic 56 oral antidiabetic medication 56 ventricular tachycardia 56 renal impairment 56 preterm deliveries 56 prostate TURP 56 hemodynamics 56 Tasigna prolongs 56 invasive aspergillosis 56 idraparinux 56 QTc 56 QT prolongation 56 nephrotoxicity 56 postoperative delirium 56 clinico pathological 56 DVT PE 56 invasive candidiasis 56 retransplantation 56 CNS systemic embolism 56 aldosterone antagonists 56 cardioembolic 56 fasting glucose levels 56 anastomotic leak 56 serum testosterone 56 acute STEMI 56 Ejection Fraction 56 POAG 56 Hashimoto thyroiditis 56 ALT flares 56 deep venous thrombosis 56 lung resection 56 coronary stenoses 56 revascularisation procedures 56 HAM D# scores 56 antihypertensive agents 56 triglyceride concentrations 56 LV systolic dysfunction 56 curative resection 56 pulmonary thromboembolism 56 stent placement 56 antiplatelet medications 56 seropositive patients 56 elevated uric acid 56 CHD coronary 56 stent thrombosis blood clots 56 TNF antagonist 56 TAXUS Liberte stent 56 #.#ng/ml 56 undergo percutaneous coronary 56 dyslipidemia hypertension 56 postmenopausal breast cancer 56 lipid levels 56 arterial thickening 56 carotid bruit 56 Recurrences 56 ductal carcinomas